| Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer (NCT04119622) | Aiping Zhou | 2019-10-08 |
| Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer (NCT04050436) | Replimune, Inc. | 2019-10-08 |
| Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring (NCT04037254) | NRG Oncology | 2019-10-08 |
| Growth Hormone Replacement Therapy for Retried Professional Football Players (NCT04121780) | Center for Neurological Studies | 2019-10-08 |
| Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021) (NCT03969901) | Merck Sharp & Dohme LLC | 2019-10-08 |
| A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC (NCT04108013) | Xuanwu Hospital, Beijing | 2019-10-08 |
| A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. (NCT04049266) | Kodiak Sciences Inc | 2019-10-08 |
| Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream (NCT04118296) | Sukma Skin Treatment | 2019-10-08 |
| Botox for the Treatment of Chronic Exertional Compartment Syndrome (NCT03922139) | University of Wisconsin, Madison | 2019-10-08 |
| Evaluation of Antibacterial Effect of Allium Sativum, Calcium Hydroxide and Their Combination in Infected Mature Teeth (NCT05050071) | Suez Canal University | 2019-10-08 |
| HLAB-002 of ANS-6637 for Alcohol Use Disorder (NCT03970109) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2019-10-08 |
| Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer (NCT03938337) | University of Alabama at Birmingham | 2019-10-08 |
| Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (NCT03833440) | Assistance Publique Hopitaux De Marseille | 2019-10-08 |
| Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM (NCT06160609) | GlaxoSmithKline | 2019-10-07 |
| A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene (NCT04123626) | ProQR Therapeutics | 2019-10-07 |
| Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults (NCT03910972) | Baylor College of Medicine | 2019-10-07 |
| Effects of Sleep Disruption on Drug Response (NCT03680287) | Johns Hopkins University | 2019-10-07 |
| Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT04126200) | GlaxoSmithKline | 2019-10-07 |
| TOLERA: Tolerance Enhancement in RA (NCT04120831) | University of Erlangen-Nürnberg Medical School | 2019-10-07 |
| Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD) (NCT04081363) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-10-07 |
| Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC) (NCT04057365) | Massachusetts General Hospital | 2019-10-07 |
| Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN (NCT03529422) | UNC Lineberger Comprehensive Cancer Center | 2019-10-07 |
| Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension (NCT03781414) | Novartis Pharmaceuticals | 2019-10-07 |
| Vitamin C in Post-cardiac Arrest (NCT03509662) | Amsterdam UMC, location VUmc | 2019-10-07 |
| Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）. (NCT04063683) | Henan Cancer Hospital | 2019-10-07 |
| Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration (NCT04040205) | Medical College of Wisconsin | 2019-10-07 |
| A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion (NCT03954041) | Remedy Pharmaceuticals, Inc. | 2019-10-06 |
| Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath (NCT04117919) | China Medical University Hospital | 2019-10-05 |
| Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease (NCT04139122) | Senju Pharmaceutical Co., Ltd. | 2019-10-05 |
| A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity (NCT03954106) | Jazz Pharmaceuticals | 2019-10-04 |
| Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists) (NCT04300881) | Wagner Macula & Retina Center | 2019-10-04 |
| Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS (NCT03920657) | Fondazione Italiana Sindromi Mielodisplastiche-ETS | 2019-10-04 |
| BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases (NCT04183062) | Nicklaus Children's Hospital f/k/a Miami Children's Hospital | 2019-10-04 |
| FX-322 in Adults With Stable Sensorineural Hearing Loss (NCT04120116) | Frequency Therapeutics | 2019-10-04 |
| ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation (NCT04082897) | Niguarda Hospital | 2019-10-04 |
| Early Metabolic Resuscitation for Septic Shock (NCT03895853) | M.D. Anderson Cancer Center | 2019-10-04 |
| A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis (NCT04162769) | Arena Pharmaceuticals | 2019-10-04 |
| Pramipexole to Target "Anhedonic Depression" (NCT04121091) | Region Skane | 2019-10-04 |
| An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD) (NCT03972501) | Azura Ophthalmics | 2019-10-04 |
| Treatment of Mild-moderate Clostridium Difficile Infection (CDI) (NCT04121169) | ImmuniMed Inc. | 2019-10-04 |
| Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO (NCT03815890) | The Netherlands Cancer Institute | 2019-10-04 |
| Utility of Sodium Lactate Infusion During Septic Shock (NCT03528213) | University Hospital, Lille | 2019-10-04 |
| Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension (NCT04114539) | Emalex Biosciences Inc. | 2019-10-04 |
| Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches (NCT04066023) | Zosano Pharma Corporation | 2019-10-03 |
| Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP) (NCT03975153) | Oregon Health and Science University | 2019-10-03 |
| Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer (NCT03955471) | Tesaro, Inc. | 2019-10-03 |
| CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma (NCT03579927) | M.D. Anderson Cancer Center | 2019-10-03 |
| 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (NCT04006522) | James Brugarolas | 2019-10-02 |
| Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma (NCT03918252) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-02 |
| Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC (NCT04594694) | Intercept Pharmaceuticals | 2019-10-02 |
| Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG (NCT04049669) | Theodore S. Johnson | 2019-10-02 |
| Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine (NCT04086212) | Iperboreal Pharma Srl | 2019-10-02 |
| Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma (NCT03901378) | Ochsner Health System | 2019-10-02 |
| Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine (NCT04025580) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-10-02 |
| Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma (NCT03695744) | Singapore General Hospital | 2019-10-02 |
| Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease (NCT04009668) | University of Michigan | 2019-10-02 |
| Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy (NCT04239846) | TWi Biotechnology, Inc. | 2019-10-02 |
| CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab (NCT03638141) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-02 |
| SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors (NCT03433183) | Sarcoma Alliance for Research through Collaboration | 2019-10-02 |
| Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders (NCT03943537) | Mclean Hospital | 2019-10-01 |
| Probiotics in Women With Primary Dysmenorrhoea (NCT04119011) | National University of Malaysia | 2019-10-01 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (NCT03800784) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-01 |
| Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers (NCT04098562) | Fakultas Kedokteran Universitas Indonesia | 2019-10-01 |
| Nicotinamide Riboside in Hospitalized Patients (NCT04110028) | Oslo University Hospital | 2019-10-01 |
| The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease (NCT04206176) | The University of The West Indies | 2019-10-01 |
| Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery (NCT01002209) | Karolinska Institutet | 2019-10-01 |
| Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization (NCT03942601) | Mercator MedSystems, Inc. | 2019-10-01 |
| A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT03873025) | University College, London | 2019-10-01 |
| Carboplatin or Olaparib for BRcA Deficient Prostate Cancer (NCT04038502) | VA Office of Research and Development | 2019-10-01 |
| Cannabidiol and Prolonged Exposure (NCT03518801) | VA Office of Research and Development | 2019-10-01 |
| A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer (NCT04111913) | Nanfang Hospital, Southern Medical University | 2019-10-01 |
| PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma (NCT04098796) | China Medical University, China | 2019-10-01 |
| Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome (NCT04160052) | M.D. Anderson Cancer Center | 2019-10-01 |
| Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study (NCT03951142) | Kyrre Eeg Emblem | 2019-10-01 |
| Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma (NCT04118166) | Kristen Ganjoo | 2019-10-01 |
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease (NCT04089150) | Australasian Gastro-Intestinal Trials Group | 2019-10-01 |
| c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI (NCT04833036) | Fudan University | 2019-10-01 |
| A Trial of Camrelizumab in Combination With Nab-paclitaxel and Famitinib as a First Line Treatment in Patients With Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer(FUTURE-C-PLUS) (NCT04129996) | Fudan University | 2019-10-01 |
| IORT on Borderline Resectable Pancreatic Cancer (NCT04090463) | Universita di Verona | 2019-10-01 |
| Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer (NCT04128800) | Tianjin Medical University Cancer Institute and Hospital | 2019-10-01 |
| Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC) (NCT03909724) | Amsterdam UMC, location VUmc | 2019-10-01 |
| Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure (NCT03863002) | Tianjin Weikai Bioeng., Ltd. | 2019-10-01 |
| Vitamin E for NASH Treatment in HIV Infected Individuals (NCT03669133) | Indiana University | 2019-10-01 |
| IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL (NCT04066920) | Deok-Hwan Yang | 2019-10-01 |
| Targeted Delivery of Chemotherapy With Ultrasound and Microbublles (NCT03458975) | University Hospital, Tours | 2019-10-01 |
| Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome (NCT03905525) | Novartis Pharmaceuticals | 2019-10-01 |
| Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen (NCT04101929) | Fudan University | 2019-10-01 |
| Effects of tDCS on Heart Rate Variability in Chronic Low Back Pain (NCT04077632) | Universidade Federal do Piauí | 2019-10-01 |
| Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma (NCT04099589) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-10-01 |
| Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation (NCT02995642) | Stanford University | 2019-10-01 |
| Eye Tracking as a Biomarker of Cannabis Effects (NCT04100590) | New York State Psychiatric Institute | 2019-10-01 |
| OTO-413 in Subjects With Speech-in-Noise Hearing Impairment (NCT04129775) | Otonomy, Inc. | 2019-10-01 |
| Implication of Fluid Strategies Upon Hepatic Outcome in Hepatobiliary Surgery (NCT03923816) | Assiut University | 2019-10-01 |
| Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis (NCT04062331) | Maimónides Biomedical Research Institute of Córdoba | 2019-10-01 |
| Oxytocin Treatment for Alcohol Use Disorders (NCT03636555) | University of North Carolina, Chapel Hill | 2019-10-01 |
| A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS (NCT04071158) | Pfizer | 2019-10-01 |
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) (NCT04734405) | ProFem GmbH | 2019-10-01 |
| Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI (NCT04148573) | Neurofix S.L. | 2019-10-01 |
| Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) (NCT04124731) | Shanghai Chest Hospital | 2019-10-01 |
| Biological Effects of Quercetin in COPD (NCT03989271) | Temple University | 2019-10-01 |